Status:

NOT_YET_RECRUITING

Esketamine Combined With PRF of DRG for Postherpetic Neuralgia

Lead Sponsor:

Beijing Tiantan Hospital

Collaborating Sponsors:

Beijing Xiaotangshan Hospital

The First Hospital of Fangshan District,Beijing

Conditions:

Postherpetic Neuralgia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) of dorsal root ganglion(DRG) against that of PRF monotherapy in patien...

Detailed Description

This study aims to determine whether the addition of esketamine to the PRF of DRG regimen can relieve pain in PHN patients. By doing so, the research endeavors to identify a rapid, effective, and safe...

Eligibility Criteria

Inclusion

  • Ages more than 18 years;
  • Pain persisting for over three months following the onset of the herpes zoster skin rash;
  • Lesions located in in the unilateral cervical, thoracic, and lumbosacral segments;
  • Having an average pain score of at least 4 on a Numeric Rating Scale (NRS, 0 = no pain, 10= worst possible pain); Planned to perform CT-guided PRF treatment of the Dorsal root ganglion(DRG)

Exclusion

  • Obstructive sleep apnoea syndrome;
  • Those who receive other more invasive treatments, such as radiofrequency thermocoagulation (RFT) of DRG.
  • A history of systemic immune diseases, organ transplantation, or cancers;
  • A history of severe cardiopulmonary, hepatic, renal dysfunction or coagulation function disorder;
  • A history of schizophrenia, epilepsy, or myasthenia gravis, delirium;
  • Comorbid hyperthyroidism or phaeochromocytoma;
  • Recent history of drug abuse;
  • Having contraindications to esketamine;
  • Communication difficulties.
  • Women who are preparing for pregnancy, in the pregnancy or lactation period.

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

186 Patients enrolled

Trial Details

Trial ID

NCT06914193

Start Date

April 1 2025

End Date

October 1 2026

Last Update

April 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100070